CorVel Co. (NASDAQ:CRVL) Shares Bought by Occudo Quantitative Strategies LP

Occudo Quantitative Strategies LP raised its stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 184.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,467 shares of the business services provider's stock after buying an additional 2,896 shares during the quarter. Occudo Quantitative Strategies LP's holdings in CorVel were worth $497,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of CRVL. Kayne Anderson Rudnick Investment Management LLC lifted its stake in CorVel by 193.7% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,714,351 shares of the business services provider's stock valued at $635,779,000 after acquiring an additional 3,768,440 shares during the period. Vanguard Group Inc. grew its holdings in shares of CorVel by 202.1% in the fourth quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider's stock worth $365,116,000 after acquiring an additional 2,195,466 shares during the period. Renaissance Technologies LLC increased its position in CorVel by 184.1% during the fourth quarter. Renaissance Technologies LLC now owns 1,858,830 shares of the business services provider's stock valued at $206,813,000 after acquiring an additional 1,204,611 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in CorVel by 187.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,545,619 shares of the business services provider's stock valued at $171,969,000 after acquiring an additional 1,007,651 shares during the period. Finally, Neuberger Berman Group LLC boosted its position in CorVel by 204.6% in the fourth quarter. Neuberger Berman Group LLC now owns 845,531 shares of the business services provider's stock worth $94,074,000 after purchasing an additional 567,984 shares during the last quarter. Institutional investors own 51.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of CorVel from a "hold" rating to a "buy" rating in a research note on Friday, April 18th.

Insider Activity at CorVel

In other CorVel news, Director Jeffrey J. Michael sold 16,523 shares of the stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the completion of the transaction, the director now owns 551,787 shares of the company's stock, valued at $64,553,561.13. This represents a 2.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 47.57% of the stock is currently owned by corporate insiders.

CorVel Trading Up 0.1%

CorVel stock traded up $0.14 during trading on Wednesday, reaching $113.81. The company had a trading volume of 18,532 shares, compared to its average volume of 119,442. The firm has a market capitalization of $5.84 billion, a price-to-earnings ratio of 67.00 and a beta of 1.10. The firm's 50-day simple moving average is $111.61 and its 200 day simple moving average is $116.64. CorVel Co. has a 52 week low of $76.53 and a 52 week high of $128.61.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.